1. Home
  2. AZTA vs WVE Comparison

AZTA vs WVE Comparison

Compare AZTA & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$23.27

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.14

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTA
WVE
Founded
1978
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
AZTA
WVE
Price
$23.27
$6.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
16
Target Price
$40.60
$29.81
AVG Volume (30 Days)
990.0K
3.1M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
60.52
N/A
EPS
N/A
N/A
Revenue
$593,821,000.00
$3,704,000.00
Revenue This Year
$6.99
N/A
Revenue Next Year
$5.98
$85.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
149.43
52 Week Low
$15.93
$5.02
52 Week High
$41.73
$21.73

Technical Indicators

Market Signals
Indicator
AZTA
WVE
Relative Strength Index (RSI) 57.13 46.80
Support Level $21.77 $6.02
Resistance Level $24.36 $7.65
Average True Range (ATR) 0.92 0.33
MACD 0.08 0.08
Stochastic Oscillator 47.10 61.84

Price Performance

Historical Comparison
AZTA
WVE

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: